B7-H6 : un nouveau signal d’alarme pour les cellules natural killer

Myriam Baratin; Éric Vivier

doi:10.1051/medsci/2010262119

Accueil

Tous les numéros

Volume 26 / Numéro 2 (Février 2010)

Med Sci (Paris), 26 2 (2010) 119-120

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 26, Numéro 2, Février 2010


Page(s)		119 - 120
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/2010262119
Publié en ligne		15 février 2010

Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22 : 329–60. [Google Scholar]
Kiessling R, Klein E, Wigzell H. « Natural » killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5 : 112–7. [Google Scholar]
Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res 2003; 90 : 127–56. [Google Scholar]
Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9 : 503–10. [Google Scholar]
Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science 2004; 306 : 1517–9. [Google Scholar]
Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319 : 675–8. [Google Scholar]
Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends Immunol 2005; 26 : 221–6. [Google Scholar]
Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19 : 197–223. [Google Scholar]
Brandt CS, Baratin M, Yi EC, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009; 206 : 1495–503. [Google Scholar]
Olive D. Corécepteurs lymphocytaires. Med Sci (Paris) 2006; 22 : 1069–74. [Google Scholar]
Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene 2008; 27 : 5944–58. [Google Scholar]
Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23 : 515–48. [Google Scholar]
Wintterle S, Schreiner B, Mitsdoerffer M, et al. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res 2003; 63 : 7462–7. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22 : 329–60. [Google Scholar]

[2] Kiessling R, Klein E, Wigzell H. « Natural » killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5 : 112–7. [Google Scholar]

[3] Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res 2003; 90 : 127–56. [Google Scholar]

[4] Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9 : 503–10. [Google Scholar]

[5] Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science 2004; 306 : 1517–9. [Google Scholar]

[6] Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319 : 675–8. [Google Scholar]

[7] Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends Immunol 2005; 26 : 221–6. [Google Scholar]

[8] Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19 : 197–223. [Google Scholar]

[9] Brandt CS, Baratin M, Yi EC, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009; 206 : 1495–503. [Google Scholar]

[10] Olive D. Corécepteurs lymphocytaires. Med Sci (Paris) 2006; 22 : 1069–74. [Google Scholar]

[11] Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene 2008; 27 : 5944–58. [Google Scholar]

[12] Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23 : 515–48. [Google Scholar]

[13] Wintterle S, Schreiner B, Mitsdoerffer M, et al. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res 2003; 63 : 7462–7. [Google Scholar]